Invention Grant
US08703432B2 Recombinant Treponema spp. proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same 失效
重组梅毒螺旋体 用于疫苗的蛋白质,针对所述蛋白质的抗体,以及包括其的诊断和治疗方法

  • Patent Title: Recombinant Treponema spp. proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
  • Patent Title (中): 重组梅毒螺旋体 用于疫苗的蛋白质,针对所述蛋白质的抗体,以及包括其的诊断和治疗方法
  • Application No.: US13576032
    Application Date: 2011-01-28
  • Publication No.: US08703432B2
    Publication Date: 2014-04-22
  • Inventor: Anna RosanderMärit Pringle
  • Applicant: Anna RosanderMärit Pringle
  • Applicant Address: SE Sollentuna
  • Assignee: Vicia Animal Health Science AB
  • Current Assignee: Vicia Animal Health Science AB
  • Current Assignee Address: SE Sollentuna
  • Agency: Browdy and Neimark, PLLC
  • International Application: PCT/SE2011/050090 WO 20110128
  • International Announcement: WO2011/093783 WO 20110804
  • Main IPC: G01N33/53
  • IPC: G01N33/53
Recombinant Treponema spp. proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
Abstract:
The present invention relates to proteins and/or fragments and derivatives thereof and their use as vaccines and in biotechnological methods. The vaccines particularly include immunogenic proteins in Treponema spp. isolated from digital dermatitis in cattle. The present invention further relates to antibodies raised against said proteins or fragments thereof, and the use of said proteins in diagnostic methods in which antibodies are detected as a sign of digital dermatitis in cattle.
Information query
Patent Agency Ranking
0/0